| Dr Rachel Elizabeth Swart, MD,PHD | |
|
2070 W Rudasill Rd Ste 130, Tucson, AZ 85704-7891 | |
| (520) 797-4468 | |
| (520) 797-4502 |
| Full Name | Dr Rachel Elizabeth Swart |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 21 Years |
| Location | 2070 W Rudasill Rd Ste 130, Tucson, Arizona |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801097266 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 36169 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Medical Center | Tucson, AZ | Hospital |
| Oro Valley Hospital | Oro valley, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arizona Oncology Associates Pc | 9638067911 | 105 |
News Archive
A transgender man in his 30's was able to carry a child after taking female hormones to reverse the effects of his female-to-male sex change treatment. The man from the West Midlands, UK is in a long-term relationship. It is not clear whether his partner is male or female. Medical ethics experts have called for a full inquiry into the issues surrounding transgender births, saying the interests of the child should not be risked to "fulfill the rights of an adult".
Botox, a medication derived from a bacterial toxin, is commonly injected to ease wrinkles, migraines, muscle spasms, excessive sweating and incontinence.
Abbott today announced that it has received U.S. Food and Drug Administration clearance for its FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System, an advanced blood glucose monitoring system designed to address the key needs of hospital customers: high accuracy, efficient operation, dual-band wireless access to immediate test results, and helps in the reduction of the risk of test strip cross-contamination.
Medtronic, Inc. today announced the Food and Drug Administration (FDA) approval of iPro2, a next generation Professional continuous glucose monitoring (CGM) system and the latest in a series of recent diabetes technology approvals and innovations from the company.
Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly results in patients developing a tolerance to the drug after repeated use and makes the drug less effective, according to researchers at Georgia State University, Kumamoto University and the University of Rochester Medical Center.
› Verified 5 days ago
| Entity Name | Arizona Oncology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578587671 PECOS PAC ID: 9638067911 Enrollment ID: O20040308001399 |
News Archive
A transgender man in his 30's was able to carry a child after taking female hormones to reverse the effects of his female-to-male sex change treatment. The man from the West Midlands, UK is in a long-term relationship. It is not clear whether his partner is male or female. Medical ethics experts have called for a full inquiry into the issues surrounding transgender births, saying the interests of the child should not be risked to "fulfill the rights of an adult".
Botox, a medication derived from a bacterial toxin, is commonly injected to ease wrinkles, migraines, muscle spasms, excessive sweating and incontinence.
Abbott today announced that it has received U.S. Food and Drug Administration clearance for its FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System, an advanced blood glucose monitoring system designed to address the key needs of hospital customers: high accuracy, efficient operation, dual-band wireless access to immediate test results, and helps in the reduction of the risk of test strip cross-contamination.
Medtronic, Inc. today announced the Food and Drug Administration (FDA) approval of iPro2, a next generation Professional continuous glucose monitoring (CGM) system and the latest in a series of recent diabetes technology approvals and innovations from the company.
Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly results in patients developing a tolerance to the drug after repeated use and makes the drug less effective, according to researchers at Georgia State University, Kumamoto University and the University of Rochester Medical Center.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Rachel Elizabeth Swart, MD,PHD Po Box 910221, Dallas, TX 75391-0221 Ph: (520) 519-7700 | Dr Rachel Elizabeth Swart, MD,PHD 2070 W Rudasill Rd Ste 130, Tucson, AZ 85704-7891 Ph: (520) 797-4468 |
News Archive
A transgender man in his 30's was able to carry a child after taking female hormones to reverse the effects of his female-to-male sex change treatment. The man from the West Midlands, UK is in a long-term relationship. It is not clear whether his partner is male or female. Medical ethics experts have called for a full inquiry into the issues surrounding transgender births, saying the interests of the child should not be risked to "fulfill the rights of an adult".
Botox, a medication derived from a bacterial toxin, is commonly injected to ease wrinkles, migraines, muscle spasms, excessive sweating and incontinence.
Abbott today announced that it has received U.S. Food and Drug Administration clearance for its FreeStyle Precision Pro Blood Glucose and Beta-Ketone Monitoring System, an advanced blood glucose monitoring system designed to address the key needs of hospital customers: high accuracy, efficient operation, dual-band wireless access to immediate test results, and helps in the reduction of the risk of test strip cross-contamination.
Medtronic, Inc. today announced the Food and Drug Administration (FDA) approval of iPro2, a next generation Professional continuous glucose monitoring (CGM) system and the latest in a series of recent diabetes technology approvals and innovations from the company.
Roflumilast, a drug recently approved in the United States to treat severe chronic obstructive pulmonary disease (COPD), increases the production of a protein that causes inflammation, which possibly results in patients developing a tolerance to the drug after repeated use and makes the drug less effective, according to researchers at Georgia State University, Kumamoto University and the University of Rochester Medical Center.
› Verified 5 days ago
Dr. Basel Skeif, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5140 E Glenn St, Tucson, AZ 85712 Phone: 520-838-3540 Fax: 520-325-3526 | |
Dr. David Spencer Hamilton Sr., MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3601 S 6th Ave, Tucson, AZ 85723 Phone: 520-792-1450 | |
Diana Silva Cantillo, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1230 S Cherrybell Stra, Tucson, AZ 85713 Phone: 520-628-8287 | |
Basel Shoua, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2070 W Rudasill Rd Ste 130, Tucson, AZ 85704 Phone: 520-797-4468 Fax: 520-797-4502 | |
Hadil Owaynat, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1501 N Campbell Ave Rm 6336, Tucson, AZ 85724 Phone: 520-626-2760 Fax: 520-626-6020 | |
Dr. David M Schwartz, DO Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 6200 N La Cholla Blvd, Tucson, AZ 85741 Phone: 520-469-8011 Fax: 520-469-8021 | |
Kenneth Alex Murachanian, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 6060 N Fountain Plaza Dr Ste 270, Tucson, AZ 85704 Phone: 520-229-2578 |